Nike shares climb ahead of gloomy sales report – 10/01/2024 at 6:00 p.m.

Nike shares climb ahead of gloomy sales report – 10/01/2024 at 6:00 p.m.

(Automated translation by Reuters, please see disclaimer October 1 – ** Shares of Nike NKE.N rose 0.84% ​​to $89.14 on Tuesday, bucking the market’s slide, ahead of its scheduled quarterly earnings release after the closing bell ** Investors and analysts expect NKE to lower its annual sales forecast in first earnings report since Elliot Hill … Read more

Nike to post biggest sales drop since COVID, analysts expect target revision – 09/30/2024 at 12:56

Nike to post biggest sales drop since COVID, analysts expect target revision – 09/30/2024 at 12:56

(Automated translation by Reuters, please see disclaimer by Ananya Mariam Rajesh and Nicholas P. Brown Investors and analysts expect Nike NKE.N to lower its annual forecast on Tuesday when it reports quarterly results, the company’s first earnings report since announcing a new chief executive early of the month. Elliott Hill, who spent 32 years at … Read more

Tony Tipton appointed as Crossject’s US Operations Director to commercialize ZEPIZURE®, an emergency treatment for epileptic seizures – 08/19/2024 at 6:48 p.m.

Tony Tipton appointed as Crossject’s US Operations Director to commercialize ZEPIZURE®, an emergency treatment for epileptic seizures – 08/19/2024 at 6:48 p.m.

Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharmaceutical company developing emergency medicines delivered with its award-winning ZENEO® needle-free auto-injector, announces the appointment of veteran healthcare executive Tony Tipton as Chief Operating Officer, U.S. With over 25 years of experience in key sectors of the commercial pharmaceutical industry, he brings expertise in corporate governance and development, … Read more

Federer-backed On maintains full-year revenue forecast after positive quarterly result, but shares fall – 08/13/2024 at 12:28

Federer-backed On maintains full-year revenue forecast after positive quarterly result, but shares fall – 08/13/2024 at 12:28

((Automated translation by Reuters, please see disclaimer (Added earnings comparison in paragraph 10 and updated stocks) by Ananya Mariam Rajesh On Holding ONON.N beat analysts’ estimates for second-quarter revenue on Tuesday on strong demand for its footwear and apparel from customers looking for fashionable products, but shares fell 9% premarket as the company maintained its … Read more

FDA Refuses to Approve First MDMA-Based PTSD Treatment – 08/09/2024 at 23:49

FDA Refuses to Approve First MDMA-Based PTSD Treatment – 08/09/2024 at 23:49

((Automated translation by Reuters, please see disclaimer (Added details to paragraphs 4 and 5) The U.S. health regulator has refused to approve a therapy based on the psychotropic drug MDMA for patients suffering from post-traumatic stress disorder, saying it could not be approved based on the data submitted, Lykos Therapeutics said Friday. Commonly referred to … Read more

Amazon Prime Video wants to expand into Hollywood – 08/07/2024 at 12:00

Amazon Prime Video wants to expand into Hollywood – 08/07/2024 at 12:00

((Automated translation by Reuters, please see disclaimer by Dawn Chmielewski and Greg Bensinger When Mike Hopkins was approached to lead Amazon AMZN.O Prime Video, his vision for the streaming service matched that widely held in Hollywood: It was nothing more than a perk for subscribers to the online retailer’s two-day delivery service. But Amazon founder … Read more

US FDA approves Servier’s brain tumor treatment – 07/08/2024 at 01:29

US FDA approves Servier’s brain tumor treatment – 07/08/2024 at 01:29

((Automated translation by Reuters, please see disclaimer Servier Pharmaceuticals said Tuesday that the U.S. Food and Drug Administration has approved the French manufacturer’s treatment for a type of brain tumor, making it the first drug to be approved in the United States for the condition. The drug, called voranigo, is used to treat a form … Read more

Samsung’s 8-layer HBM3E chips pass Nvidia’s tests and can be used, sources say – 07/08/2024 at 01:00

Samsung’s 8-layer HBM3E chips pass Nvidia’s tests and can be used, sources say – 07/08/2024 at 01:00

((Automated translation by Reuters, please see disclaimer by Fanny Potkin and Heekyong Yang Aug. 6 – (A version of Samsung Electronics’ 005930.KS) fifth-generation HBM chips has successfully passed Nvidia NVDA.O’s testing for use in its artificial intelligence (AI) processors, three sources familiar with the results said. The qualification removes a major hurdle for the world’s … Read more

The Ultimate Stock Search News Update: Latest Trends and Analysis for Investors

The Ultimate Stock Search News Update: Latest Trends and Analysis for Investors

Datasec From “Stock Search” multi-functional chart [Good material]―――――――――――― ■West Holdings1407> [東証S]The company will buy back up to 1 million shares (3 billion yen), which is 2.46% of the number of issued shares (excluding treasury shares). The purchasing period is from April 15th to October 31st. ■Interlife Holdings1418> [東証S] Ordinary profit for this term increased by … Read more

Argan AGX.N Stock Soars 22.7% to Reach Six-Year High as Revenue Surges

US FDA approves Servier’s brain tumor treatment – 07/08/2024 at 01:29

(Automated translation by Reuters, please see disclaimer April 12 – **Shares of engineering services company Argan AGX.N up 22.7% to $60.50 ** Stock hits six-year high ** Company’s Q4 revenue rises 38.5% to $164.55 million vs. $161.60 million forecast – LSEG data ** The increase in turnover is attributable to increased profits from several energy … Read more